| Business: |
(Incorporated in the Cayman Islands)
We intend to leverage the expertise and network of Vickers Venture Partners, or “VVP,” a venture capital firm affiliated with our executive officers, to take advantage of its deal flow, strong networks and technical expertise in assisting us in consummating an initial business combination. VVP was co-founded in 2004 by Dr. Jeffrey Chi, our Chairman and Chief Executive Officer, along with Dr. Finian Tan (an advisor of ours), Dr. Khalil Binebine, and Dr. Damian Tan. VVP has offices in Singapore, Shanghai, San Francisco, and New York and has invested in portfolio companies in North America, Europe and Asia.
VVP focuses on early-stage investments in deep-tech industries, including biotechnology, healthcare, energy and material sciences. VVP has a diverse team of 26 professionals with experience across multiple industries. VVP has raised six funds totalling $650M since inception, with the two most recent funds focused on identifying and nurturing groundbreaking innovations and visionary entrepreneurs who have the potential to reshape industries and create lasting value. The portfolio includes companies tackling problems such as plastics pollution, energy sustainability, and intractable and prevalent diseases such as osteoarthritis, obesity, kidney failure and infectious diseases.
Dr. Jeffrey Chi is currently the Vice Chairman of Asia of VVP. He was the Chief Executive Officer of Vickers Vantage Corp I (“Vickers 1”), a SPAC that successfully consummated a business combination with Scilex Holdings in November 2022. As of December 31, 2024, the last reported sales price of Scilex Holdings common stock and warrants was $0.43 per share and $0.21 per warrant, respectively. Dr. Chi was the chairman of Singapore Venture Capital and Private Equity Association from 2013 to 2017, was on the boards of Jing-Jin Electric International Co. Ltd., Tenfen Technology Co. Ltd., Kuyun Interactive Technology Ltd., Matchmove Pay Pte. Ltd. and Cambridge Real Estate Investment Management and was an alternate director of Asia Food Channel. Prior to VVP, Dr. Chi was a Corporate Finance Specialist and an Executive Director at Pegasus Capital where he had managed engagements for a wide range of clients in both the public and private sectors. Dr. Chi’s operational background includes working on the management team of an engineering and construction group where he oversaw operations in Singapore, Malaysia, Taiwan and Indonesia.
(Note: Vickers Vantage Corp. II filed its S-1 dated April 3, 2025, without disclosing it’s IPO’s terms. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one right to receive one-tenth (1/10) of one Class A ordinary share upon consummation of an initial business combination.)
|
